Leonteq Securities’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
Leonteq Securities's CAI Position: Q3 2026 in Review
Leonteq Securities reduced its Caris Life Sciences (CAI) stake by 50% in Q3 2026, selling an estimated $11.2K and leaving 500 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #967.
Leonteq Securities first reported a position in CAI in Q2 2026 and has held it in 2 quarters since. The position peaked at $17.8K in Q2 2026. 255 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- Leonteq Securities held 500 shares of Caris Life Sciences worth $15.3K as of Q3 2026.
- Leonteq Securities sold 500 Caris Life Sciences shares in Q3 2026, an estimated $11.2K.
- Caris Life Sciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #967 holding.
- Leonteq Securities first reported a position in Caris Life Sciences in Q2 2026 and has held it in 2 quarters since.
- Leonteq Securities's Caris Life Sciences position peaked at $17.8K in Q2 2026.
- 255 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.